Evidence map›Paper›PMID 36979445›Full record

ArticleBiomolecules2023

Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission.

Elsa Isingrini, Chloé Guinaudie, Léa Perret, Elisa Guma, Victor Gorgievski, Ian D Blum, Jessica Colby-Milley, Maryia Bairachnaya, Sébastien Mella, Antoine Adamantidis and 2 more

Open access · goldFull text read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The locus coeruleus maintains core body temperature and protects against hypothermia during dexmedetomidine-induced sedation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Elsa IsingriniDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.ORCID 0000-0002-0698-4237
Chloé GuinaudieDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.
Léa PerretDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.ORCID 0000-0003-4506-4414
Elisa GumaDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.ORCID 0000-0003-4651-8529
Victor GorgievskiDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.
Ian D BlumDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.ORCID 0000-0001-6999-8364
Jessica Colby-MilleyDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.
Maryia BairachnayaDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.ORCID 0000-0001-9719-1963
Sébastien MellaCytometry and Biomarkers Platform, Unit of Technology and Service, Institut Pasteur, Université de Paris, F-75015 Paris, France.ORCID 0000-0002-8679-5718
Antoine AdamantidisDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.ORCID 0000-0003-2531-5175
Kai-Florian StorchDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.
Bruno GirosDepartment of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, QC H4H 1R3, Canada.ORCID 0000-0001-5876-9822
Douglas Mental Health University Institute · CACentre National de la Recherche Scientifique · FRInstitut Pasteur · FRUniversity of Bern · CH

Funding

CIHR 201309OG-312343-PTCIHR 201803PJT-399980-PT
6 · The paper itself

Abstract

Noradrenaline (NE) plays an integral role in shaping behavioral outcomes including anxiety/depression, fear, learning and memory, attention and shifting behavior, sleep-wake state, pain, and addiction. However, it is unclear whether dysregulation of NE release is a cause or a consequence of maladaptive orientations of these behaviors, many of which associated with psychiatric disorders. To address this question, we used a unique genetic model in which the brain-specific vesicular monoamine transporter-2 (VMAT2) gene expression was removed in NE-positive neurons disabling NE release in the entire brain. We engineered VMAT2 gene splicing and NE depletion by crossing floxed VMAT2 mice with mice expressing the Cre-recombinase under the dopamine β-hydroxylase (DBH) gene promotor. In this study, we performed a comprehensive behavioral and transcriptomic characterization of the VMAT2DBHcre KO mice to evaluate the role of central NE in behavioral modulations. We demonstrated that NE depletion induces anxiolytic and antidepressant-like effects, improves contextual fear memory, alters shifting behavior, decreases the locomotor response to amphetamine, and induces deeper sleep during the non-rapid eye movement (NREM) phase. In contrast, NE depletion did not affect spatial learning and memory, working memory, response to cocaine, and the architecture of the sleep-wake cycle. Finally, we used this model to identify genes that could be up- or down-regulated in the absence of NE release. We found an up-regulation of the synaptic vesicle glycoprotein 2c (SV2c) gene expression in several brain regions, including the locus coeruleus (LC), and were able to validate this up-regulation as a marker of vulnerability to chronic social defeat. The NE system is a complex and challenging system involved in many behavioral orientations given it brain wide distribution. In our study, we unraveled specific role of NE neurotransmission in multiple behavior and link it to molecular underpinning, opening future direction to understand NE role in health and disease.

Indexed as

BrainTranscriptomeAnimalsAntidepressive AgentsDepressionMiceNorepinephrineAntidepressive AgentsNorepinephrineanxietycircadian rhythmscocaine sensitizationdepressionnoradrenalinesleepSV2c

Identifiers

PMID36979445
PMCPMC10046559
OpenAlexW4324056738

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read75
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.